islander11/iStock via Getty Images Intapp (NASDAQ:INTA) shares fell more than 4% in premarket trading on Monday as Oppenheimer downgraded the software company, citing worries over the impact of artificial intelligence and increased competition. Although there has been a lot of buzz around AI in the tech landscape, there are concernsContinue Reading
Andrii Dodonov Update 2.00PM EST: Adds latest share move and Oppenheimer’s downgrade Cell therapy developer Cartesian Therapeutics (NASDAQ:RNAC) announced Tuesday that its lead asset, Descartes-08, reached the main goal in a mid-stage trial against the muscle disorder myasthenia gravis (MG). In conjunction with the data, the Gaithersburg, Maryland-based biotech announcedContinue Reading
Tryaging/iStock via Getty Images Oppenheimer listed four stocks that could be great buys as industrials look tactically attractive. According to an Oppenheimer Technical Analysis note, the S&P 500 Equal Weight Industrials ETF (NYSEARCA:RSPN) has seen “key leadership” through the bull cycle “by stair-stepping higher on a relative basis.” Analyst AriContinue Reading
Nikada/E+ via Getty Images The SPDR S&P Capital Markets ETF (NYSEARCA:KCE) continues to trend higher on both absolute and relative basis. The sticker is up 8.34% year-to-date, and 27.27% from a year ago. Oppenheimer analysts said they see “a decade-long relative base that is reversing higher” and “this is ourContinue Reading
greenbutterfly/iStock via Getty Images The software sector has had a falling MO score since early June, but Oppenheimer analysts see relative strength through the correction. An MO score is based on a stock’s six-, nine-, and 12-month risk-adjusted return with the last month removed. According to an Oppenheimer Technical Analysis,Continue Reading
syahrir maulana Growth in investing continues to be an attractive portfolio option due to its exposure to large-cap leadership and small-cap rotation, Oppenheimer analysts said in a Technical Analysis note. The Russell 2000 Growth (NYSEARCA:IWM) has been basing compared to the Russell 1000 Value (IWD) for the last two years,Continue Reading
sefa ozel/E+ via Getty Images Kyndryl Holdings’ (NYSE:KD) stock rose about 2% on Thursday after Oppenheimer initiated coverage with an Outperform rating. The firm has set a $33 price target on shares of the company, which provides IT infrastructure and cloud services. Analysts led by Ian Zaffino noted that, withContinue Reading
Pgiam/iStock via Getty Images Oppenheimer downgraded respiratory device maker ResMed (NYSE:RMD) to Perform from Outperform on Tuesday, citing an “air pocket” for the stock in the wake of encouraging data for Eli Lilly’s (NYSE:LLY) weight loss therapy tirzepatide in obstructive sleep apnea (OSA). The maker of CPAP (continuous positive airwayContinue Reading
georgeclerk Oppenheimer has initiated Gossamer Bio at outperform expressing optimism on seralutinib, its inhaled tyrosine kinase inhibitor for pulmonary arterial hypertension (PAH). The firm has a $9 price target (~984% upside based on June 24 close). Analyst Andreas Argyrides said that the candidate’s safety and efficacy profile makes it “aContinue Reading
sx70 Twenty-two stocks in the Nasdaq 100 (NASDAQ:QQQ) have hit new highs as of the middle of June. “We see their ability to reach this new price high ahead of the underlying index as an indication of relative strength,” Oppenheimer technical analyst Ari Wald said. He picked eight stocks fromContinue Reading
